# Hibiscus BioVentures

Hibiscus BioVentures is a Venture Capital based in Rockville, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Rockville, United States
- **Region:** North America
- **Address:** Rockville, MD, United States
- **Founded:** 2019
- **Assets under management:** Undisclosed
- **Website:** hibiscusbio.com
- **LinkedIn:** https://www.linkedin.com/company/hibiscus-bioventures

## Regulatory record

- **Reports private funds:** No

## About

Hibiscus BioVentures is a venture studio founded in 2019 in Rockville, Maryland. The company was formerly known as Orchid BioVentures. It operates a venture capital arm that invests in biotechnology companies, including AsclepiX Therapeutics in a Series A - II investment on July 26, 2023. Hibiscus BioVentures has made 2 investments.

## Sectors

- Life Sciences & Healthcare
- Biotechnology

## Questions

### What is Hibiscus BioVentures' investment focus?

The firm targets early-stage and expansion-stage investments in biotechnology, medical devices, and life sciences tools. Its mandate emphasizes capital-efficient therapeutics and platform technology companies, often before they reach revenue or pivotal clinical data.

### Where does Hibiscus BioVentures source its deals?

Proximity to the National Institutes of Health, Johns Hopkins University, and the Maryland biotech corridor is central to its sourcing model. The firm is positioned to access investigator-led spinouts and early licensing opportunities emerging from these public research institutions.

### Who are the principals leading Hibiscus BioVentures?

Named principals and the investment team structure are not publicly disclosed in the sources consulted. The firm maintains a low profile, typical of a boutique life sciences investor without active press outreach.

### How large is Hibiscus BioVentures by assets under management?

AUM is not publicly disclosed. No regulatory filings or press reports specifying fund size or total capital deployment were located. The firm's AUM status is therefore listed as undisclosed.

## Related profiles

- [Hi2 Investment Management](https://altss.com/profile/hi2-investment-management)
- [Hibishin Capital](https://altss.com/profile/hibishin-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/hibiscus-bioventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology